Zylox-Tonbridge Medical Technology Co., Ltd. (Stock Code: 2190.HK)
Zylox-Tonbridge is a publicly listed company on the Hong Kong Stock Exchange (Stock Code: 2190.HK), recognized as a reliable partner in the peripheral and neurovascular interventional medical device market. Guided by our mission of "Innovation for Quality Life," we are dedicated to advancing healthcare through cutting-edge technologies and comprehensive medical solutions.
Since our establishment in 2012, we have built a robust portfolio of over 50 products, addressing the growing demands of neurovascular and peripheral vascular interventions. With strong research and development capabilities, advanced manufacturing systems, and a track record of successful product commercialization, Zylox-Tonbridge has established itself as the market leader in China and is steadily expanding its presence in international markets.
By partnering with healthcare professionals and distributors worldwide, we are committed to improving patient outcomes and advancing standards in medical care. Together, we are building a healthier future driven by innovation and quality.
Company Details
- Employees
- 22
- Founded
- -
- Address
- Zylox-Tonbridge Industrial Park, No. 270 Shuyun Road, Yuhang District, Hangzhou,zhejiang 311121,china
- Industry
- Medical Device
- Website
- zyloxmedical.com
- HQ
- Hangzhou, Zhejiang
Zylox-Tonbridge Questions
Zylox-Tonbridge's website is zyloxmedical.com
Zylox-Tonbridge's LinkedIn profile is https://cn.linkedin.com/company/zyloxtb
Zylox-Tonbridge has
22 employees.
View email and phone details for 22
employees at Zylox-Tonbridge.
Zylox-Tonbridge's industry is
Medical Device
Zylox-Tonbridge's top competitors are
Cagent Vascular,
Nucryo Vascular, Inc.,
S3v Vascular Technologies,
Noah Medical,
Zylox-Tonbridge Medical Technology Co., Ltd,
Veryan Medical,
Otsuka Medical Devices Co., Ltd.,
Elixir Medical Corporation,
Transit Scientific,
Recor Medical.
Zylox-Tonbridge's categories are Medical Device
Zylox-Tonbridge's founding year is 2012
